Biodesix (NASDAQ:BDSX) outlined its current commercial focus, growth priorities, and financial milestones during a ...
The experience features surgical robotic technology designed to assist with lung cancer diagnosis and treatment. Lung cancer is often found in patients aged 65 and older. Dr. Angel Nunez, a ...
Kalei Martin, a mom of two from Sacramento, was 28 when she began experiencing severe stomach pain, bleeding and other ...
DeepHealth, a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), ...
Introduction Incidental pulmonary nodules (IPNs) are commonly encountered on chest radiographs (CXRs) performed for routine clinical indications and may represent early manifestations of significant ...
When Lesley Scott received a letter inviting her for a routine check up, she didn't think anything was wrong. And when she ...
It can be surprising to learn that lung cancer can develop in people who have never smoked. In fact, up to 20% of lung ...
Daiichi Sankyo announced that the first patient has been dosed in the global phase 3 TROPION-Lung17 trial. The study is evaluating DATROWAY in patients with locally advanced or metastatic nonsquamous ...
Median Technologies (FR0011049824, ALMDT, "Median" or the "Company"), developer of eyonis®, a suite of artificial intelligence (AI)-powered Software as Medical Devices (SaMDs) for early cancer ...
Diffuse pulmonary meningiotheliomatosis (DPM) and minute pulmonary menigiothelial-like nodules (MPMNs) are rare pulmonary pathologies often detected incidentally. These lesions are often benign.
As a nonsmoker lung cancer hasn't been a concern of mine, but I recently heard it can affect people who have never smoked. If ...
Ohio University researchers have discovered what may be a new way to fight lung cancer that is resistant to other treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results